• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: COVID-19

DMTs and vaccine response in MS: the evidence to date

July 27, 2021  

COVID vaccination and anti-CD20s – an update

June 28, 2021  

SARS-CoV-2 variants – an update

June 16, 2021  

COVID vaccine interchangeability – what is the evidence?

June 8, 2021  

COVID-19 mortality in MS patients: a systematic review

June 1, 2021  

Slide deck: COVID-19 – Epidemiology in Canada (May 17, 2021)

May 17, 2021  

Variable vaccine efficacy against CoV-2 variants

May 11, 2021  

mRNA vaccines preferred: new NACI recommendation

May 5, 2021  

Thrombotic risk and COVID-19 vaccines: new data and disputes

April 29, 2021  

COVID variants: is one dose better than nothing?

April 26, 2021  
Previous
1
2
3
4
5
Next

Browse by Topic

  • MS (427)
  • EPILEPSY (37)
  • ECTRIMS 2025 (7)
  • BIOMARKERS IN MS (60)
  • Library (18)
  • CLINICAL CASES IN MS (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • High-efficacy DMTs for MS: the year in review posted on December 1, 2025
  • CNS effects of Wegovy (semaglutide) posted on February 28, 2023
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions